trending Market Intelligence /marketintelligence/en/news-insights/trending/8fgjaK1ChgOajqc2rkSu0Q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Bioasis closes C$1.3M private placement of units

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Bioasis closes C$1.3M private placement of units

Bioasis Technologies Inc. issued a total of 4,588,978 units at 28 Canadian cents apiece in a previously announced private placement, raising C$1.3 million gross proceeds.

Each unit consisted of a common share and one share purchase warrant, with the warrants exercisable to buy an additional share at 60 Canadian cents apiece within a 48-month period after the offering's closing.

Net proceeds will be used to support ongoing research and development, clinical development, manufacturing and other activities, as well as for working capital and general corporate purposes.

Guilford, Conn.-based Bioasis develops products to diagnose and treat neurological diseases and disorders using its proprietary technology.